The Expression of Indoleamine-2,3-dioxygenase in Non-small-cell Lung Cancer
10.3870/j.issn.1672-0741.2010.01.003
- VernacularTitle:吲哚胺-2,3-双加氧酶在非小细胞肺癌中的表达
- Author:
Junzhi XIA
;
Jianbao XIN
;
Ming BAI
- Publication Type:Journal Article
- Keywords:
Indoleamine-2,3-dioxygenase;
immunotolerance;
non-small cell lung cancer
- From:
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
2010;39(1):9-12
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the expression and significance of indoleamine-2,3-dioxygenase(IDO)in non-small-cell lung cancer(NSCLC).Methods Thirty-eight cases of lung cancer tissues and 10 cases of paracancerous normal lung tissue were collected.The semiquantitative immunohistochemistry was used to detect the positive rate of IDO and fluorescent quantitative PCR to detect the level of IDO mRNA in the lung tissues respectively.Results The positive rate of IDO and the level of IDO mRNA in NSCLC group were significantly higher than in paracancerous normal lung tissues(P＜0.05).There was no significant difference in the positive rate of IDO and the level of IDO mRNA between the adenocarcinoma group and the squamous cell carcinoma group(P＞0.05).Statistically,there was significant difference in positive rate of IDO and the level of IDO mRNA among low,middle and high differentiation groups(P＜0.05).There was significant difference in positive rate of IDO and the level of IDO mRNA between the lymph node metastasis and non-metastasis groups(P＜0.05).Conclusion The high expression of IDO in NSCLC is correlated with the degree of differentiation and the metastasis of lymph nodes,but not with the pathological types.
